Inexpensive Anti-Gout Drug May Help Fight Against Progression of Colorectal Adenomas

Allopurinol, an inexpensive anti-gout medication, may help stop the progression of colorectal adenomas, according to a news release by the American Association for Cancer Research.

Advertisement

Researchers found the presence of colorectal tumor tissue was markedly decreased in patients with colorectal polyps assigned to take allopurinol, according to the preliminary results of a study. Colorectal tumor tissue contain high levels of reactive oxygen metabolites that inhibit programmed cell death, which is a mechanism involved in cancer control. Researchers are continuing to test the effect of ROM scavengers, such as allopurinol, to measure their effects on chemoprevention.

Read the AACR news release about allopurinol.

Read other coverage about colorectal cancer:

Researchers Urge for Revisions to Guidelines for Serrated Polyp Surveillance

Large, Serrated Polyps Carry Greater Risk of Colorectal Cancer Than Other Factors

Researchers Suggest Non-Steroidal Anti-Inflammatory Drugs Prevent Colon Cancer

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.